Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Stephen Padilla, 31 Jan 2020
The combination of ivermectin 1% cream (IVM) and doxycycline 40-mg modified-release capsules (DMR) delivers faster responses, better response rates and greater satisfaction compared with monotherapy in patients with severe rosacea, a recent study has shown.
26 Jun 2020
Dapagliflozin 5 mg and 10 mg FC tab
26 Jun 2020
Apalutamide 60 mg film-coated tab

DG Speaks: NHMS 2019, the NCD war, and the roles of pharmacists

Rachel Soon
Medical Writer
28 Aug 2020
Tan Sri Dato' Seri Dr Noor Hisham Abdullah, Director-General of Health, MOH. (Photo credit: Corporate Communication Unit, MOH)

Malaysians need to start viewing non-communicable diseases (NCDs) as an emergency, says MOH Director-General of Health Tan Sri Dato' Seri Dr Noor Hisham Abdullah, in response to the recently published National Health and Morbidity Survey (NHMS 2019).

In June, among the stream of headlines covering the COVID-19 pandemic, the publication of the NHMS 2019 results made a quieter splash, revealing concerning trends in NCD prevalence among Malaysians (see infographic).

Speaking in an interview with MIMS Pharmacist, Noor Hisham noted that an estimated 91.5% of COVID-19 deaths in Malaysia were associated with at least one NCD, demonstrating the need to invest in NCD prevention and control as an essential foundation for security and preparedness.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Stephen Padilla, 31 Jan 2020
The combination of ivermectin 1% cream (IVM) and doxycycline 40-mg modified-release capsules (DMR) delivers faster responses, better response rates and greater satisfaction compared with monotherapy in patients with severe rosacea, a recent study has shown.
26 Jun 2020
Dapagliflozin 5 mg and 10 mg FC tab
26 Jun 2020
Apalutamide 60 mg film-coated tab